Saturday, September 21, 2024

Roche to halt lung-cancer drug trial after disappointing data

Must read




Roche Holding said it plans to halt a mid- and late-stage clinical study for a combination of drugs to treat lung cancer after it failed to meet the trial’s primary efficacy goals.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article